Literature DB >> 11728953

A comparison of the clinical, histopathologic, and ultrastructural phenotypes in carriers of X-linked and autosomal recessive Alport's syndrome.

H Dagher1, M Buzza, D Colville, C Jones, H Powell, R Fassett, D Wilson, J Agar, J Savige.   

Abstract

Previous series that described phenotypes in carriers of Alport's syndrome did not distinguish genetically between carriers of X-linked and autosomal recessive disease. In this study, modes of inheritance in unselected families with Alport's syndrome associated with two city and two provincial hospitals were determined using microsatellite markers, and carriers of disease haplotypes were identified within these families. All 47 carriers (100%) from 18 families with X-linked Alport's syndrome had dysmorphic hematuria on phase-contrast microscopy, but few developed renal failure (3 of 40 carriers; 8%), clinical hearing loss (2 of 45 carriers; 4%), retinopathy (1 of 30 carriers; 3%), or lenticonus (0 of 30 carriers; 0%). Eleven of the 14 carriers (79%) from 2 families with autosomal recessive disease had dysmorphic hematuria, but none had renal failure, clinical hearing loss, retinopathy, or lenticonus. Urinary red blood cell counts in carriers of X-linked Alport's syndrome were greater than those in carriers of autosomal recessive disease (P < 0.0001), but the frequency of proteinuria and hypertension and levels of proteinuria were not different. There was more tubulointerstitial damage in carriers of X-linked disease (P = 0.012); however, carriers of autosomal recessive disease had more widespread and more uniform thinning of the glomerular basement membrane (P < 0.0001) and less lamellation (P < 0.04).

Entities:  

Mesh:

Year:  2001        PMID: 11728953     DOI: 10.1053/ajkd.2001.29217

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  15 in total

1.  A female with X-linked Alport syndrome and compound heterozygous COL4A5 mutations.

Authors:  Mardhiah Mohammad; Ranjit Nanra; Deb Colville; Paul Trevillian; Yanyan Wang; Helen Storey; Frances Flinter; Judy Savige
Journal:  Pediatr Nephrol       Date:  2013-12-12       Impact factor: 3.714

2.  The effect of progressive glomerular disease on megalin-mediated endocytosis in the kidney.

Authors:  Lotte Vinge; George E Lees; Rikke Nielsen; Clifford E Kashtan; Anne Bahr; Erik I Christensen
Journal:  Nephrol Dial Transplant       Date:  2010-03-02       Impact factor: 5.992

3.  [Bilateral visual loss in a young male patient].

Authors:  N Terai; F Raiskup
Journal:  Ophthalmologe       Date:  2012-05       Impact factor: 1.059

4.  Persistent familial hematuria in children and the locus for thin basement membrane nephropathy.

Authors:  Kesha Rana; Yan Yan Wang; Harley Powell; Colin Jones; David McCredie; Mark Buzza; Madhara Udawela; Judy Savige
Journal:  Pediatr Nephrol       Date:  2005-10-19       Impact factor: 3.714

5.  Alport retinopathy results from "severe" COL4A5 mutations and predicts early renal failure.

Authors:  Rachel Tan; Deb Colville; Yan Yan Wang; Lin Rigby; Judy Savige
Journal:  Clin J Am Soc Nephrol       Date:  2009-12-03       Impact factor: 8.237

6.  The use of ocular abnormalities to diagnose X-linked Alport syndrome in children.

Authors:  Ke Wei Zhang; Deb Colville; Rachel Tan; Colin Jones; Stephen I Alexander; Jeffrey Fletcher; Judy Savige
Journal:  Pediatr Nephrol       Date:  2008-03-15       Impact factor: 3.714

7.  Retinal basement membrane abnormalities and the retinopathy of Alport syndrome.

Authors:  Judy Savige; John Liu; Delia Cabrera DeBuc; James T Handa; Gregory S Hageman; Yan Yan Wang; John D Parkin; Brendan Vote; Rob Fassett; Shirley Sarks; Deb Colville
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-10-22       Impact factor: 4.799

Review 8.  Opinion: Ocular features aid the diagnosis of Alport syndrome.

Authors:  Judy Savige; Deb Colville
Journal:  Nat Rev Nephrol       Date:  2009-06       Impact factor: 28.314

Review 9.  DNA variant databases improve test accuracy and phenotype prediction in Alport syndrome.

Authors:  Judy Savige; Elisabet Ars; Richard G H Cotton; David Crockett; Hayat Dagher; Constantinos Deltas; Jie Ding; Frances Flinter; Genevieve Pont-Kingdon; Nizar Smaoui; Roser Torra; Helen Storey
Journal:  Pediatr Nephrol       Date:  2013-05-30       Impact factor: 3.714

10.  Alport Syndrome in Women and Girls.

Authors:  Judy Savige; Deb Colville; Michelle Rheault; Susie Gear; Rachel Lennon; Sharon Lagas; Moira Finlay; Frances Flinter
Journal:  Clin J Am Soc Nephrol       Date:  2016-06-10       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.